Physician profile
Lee Harrison
NPI 1275507881
$69,591.09
in general payments reported to CMS, 2019-2025
6 companies · $10K in 2025
The $10K reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $1,273 · 2022: $10K · 2023: $4,443 · 2024: $8,157 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $13K · Consulting Fee: $5,010 · Food and Beverage: $4,312 · Grant: $800 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $95.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,826.87 |
| Consulting Fee | $5,010.00 |
| Food and Beverage | $4,311.99 |
| Grant | $800.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $95.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $27,432.01 | 2019 | |
| Pfizer INC. | $17,934.42 | 2019-2025 | |
| Pfizer International LLC | $14,503.73 | 2019-2024 | |
| Seqirus USA INC | $6,499.40 | 2025 | |
| Glaxosmithkline, LLC. | $2,859.58 | 2022-2024 | |
| Genzyme Corporation | $361.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.